Homepage - JADPRO

For updated information about JADPRO Live 2024, please visit JADPROLive.com

CURRENT ISSUE Current Issue Cover

VOL 15 NO 5 • Jul/Aug 2024

IN THIS ISSUE

Impact of an Oncology Clinical Pharmacist Intervention on Clinical Trial Enrollment in The US Oncology Network’s MYLUNG Consortium

Elizabeth Koselke,(1), Lisa C. Kaspin-Powell,(2), Shannon Hough,(1), Joshua Howell,(1), Nicholas J. Robert,(2), Marcus A. Neubauer,(3), Susie A. Bullock,(4), Jennifer M. Walberg,(4), Melissa Rammage,(5), James E. Butrynski,(6), David Hakimian,(7), Robert M. Jotte,(8), Michael W. Meshad,(9), Kashif Ali,(10), David Michael Waterhouse,(11), Robert L. Coleman,(4), and Makenzi Colleen Evangelist,(12)

Evaluating the User-Perceived Benefit of a Virtual Lung Cancer Patient Education and Support Community: LVNG With Lung Cancer

Mona L. Martin,(1) RN, MPA, Kristin Bucklen,(2) BS, MBA, Lise J. Hall,(3) BA, MBA, Dann Wonser,(4) MA, LPC, Genevieve de Renne,(4) MA, OTR/L, FAOTA, and Beth Sandy,(5) MSN

A Real-World Evidence Primer for Advanced Practice Providers: Integrating P-Reality X Into Shared Decision-Making for People With HR+/HER2− Metastatic Breast...

Sarah Donahue,(1) MPH, NP, Joanne C. Ryan,(2) PhD, RN, and Kimberly Podsada,(3) MSN, NP-C

Diversity, Equity, and Inclusion in Multiple Myeloma: A Call to Action

Rebecca Lu,(1) MSN, FNP-C, Joseph D. Tariman,(2) PhD, MBA, ANP-BC, FAAN, Donna Catamero,(3) ANP-BC, OCN, CCRC, Michaela Hillengass,(4) RN, CPT, ACSM, and Kimberly Noonan,(5) DNP, ANP-BC, AOCN®

TODAY'S NEWS

Does Bilateral Mastectomy for Unilateral...

The results of a contemporary U.S. population–base...

Patients With Prostate Cancer Social Fac...

Based on the results of a retrospective cohort stu...

Update on LEANer Trial in Patients With ...

Guest Editor’s Note: Chemotherapy and its side eff...

Triplet as Initial Salvage Treatment for...

In a long-term analysis reported in the Journal of...

New Study Highlights Improvements in Tre...

The advancement of retinoblastoma treatment over t...

More News From Today

EDITORIALS & COMMENTARY

Advanced Practitioners as Allies and Advocates

Advanced practitioners (APs) are a growing proportion of the health-care team...

Rare Myeloproliferative Neoplasm w/CSF3R

Cases of chronic neutrophilic leukemia (CNL) are extremely rare and easily missed...

Management of Carcinoid Syndrome

Diarrhea is often a presenting symptom in patients with neuroendocrine tumors...

APs: Collaborators in Radiation Oncology

Advanced practitioners, including physician assistants and nurse practitioners, are medical professionals with...

Axicabtagene Ciloleucel: CAR T-Cell Therapy

Axicabtagene ciloleucel (axi-cel) is an anti-CD19 CAR T-cell therapy that has demonstrated efficacy...

More Editorials & Commentary

PREVIOUS HIGHLIGHTS

Gemcitabine/Eribulin in Cisplatin-Inelig...

In the final analysis from a phase II California C...

Deintensified Chemoradiotherapy for HPV-...

In a phase II trial reported in the Journal of Cli...

USPSTF Recommendation on Risk Assessment...

As reported in JAMA, the U.S. Preventive Services ...

Incidence of HPV-Associated Head and Nec...

In a study by Mahal et al published in Cancer Epid...

Racial Reporting and Representation in O...

New research published by Loree et al in JAMA Onco...

More Highlights

LATEST TWEETS

Error loading Partial View script (file: ~/Views/MacroPartials/JADPRO Twitter Feed.cshtml)

More Tweets

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.